OPT Opthea Limited
13.12
-0.09 -1%
Previous Close
13.2
Open
13.05
52 Week Low
10.22
52 Week High
13.9999
Market Cap
$553,558,195
Shares
42,208,021
Float
42,208,021
Enterprise Value
$520,679,946
Volume
6,273
Av. Daily Volume
0
Upcoming Catalysts
| Drug | Stage | Catalyst Date |
|---|---|---|
|
OPT-302
Diabetic macular edema
|
Phase 1/2
Phase 1/2
|
Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 14-day FREE TRIAL.
|
|
OPT-302
Wet age-related macular degeneration (AMD)
|
Phase 3
Phase 3
|
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien.
|